March

• Equity Investment in Dongkoo bio & pharma

April

• Approved ISO13485:2016

July

• Completion of Filler Manufacturing Facility

September

• GMP Inspection of Filler Manufacturing Facility
• Initiating overseas sales in CIS, SEA countries
  with export permit by MFDS

November

• Obtained GMP manufacturing license from the MFDS in Korea

December

• Submission of IDE for Phase 3 Clinical Trial in Korea

February

• Philippines PFDA Registration Application Completed

April

• Clinical Trial phase 3 by MFDS (KFDA) approved

July

• Development and Manufacturing of Finished Dermarosa Touch Skinbooster

September

• The phase 3 clinical trial is scheduled for completion.